Clinical trial patients don't care about study sponsors or physician conflicts of interest

Many patients will volunteer for a clinical trial if asked, even if the physician who inquires is a stockholder in the sponsoring company or has other potential conflicts of interest, a Johns Hopkins study demonstrates.

Results of the study, to be presented Nov. 11 at the American Heart Association's 76th annual Scientific Sessions in Orlando, Fla., also suggest that the majority of clinical trial patients don't care if their physician discloses such conflicts of interest to them.

"There's been an incredible push by academicians and health policy makers to make sure conflicts of interest are minimized," says Joel B. Braunstein, M.D., M.B.A., lead author of the study and an assistant professor of medicine at Hopkins. "While ethically, this is readily justified, our study quite surprisingly suggests that patients don't really care about these relationships. A patient's decision to enroll in a clinical trial involves many more factors, including interest in finding a new medication that might help him or her."

Braunstein and colleagues approached 1,132 patients from 13 Maryland-based cardiology and internal medicine outpatient clinics about participating in a hypothetical clinical trial for a new drug to help prevent heart attack. At random, they told patients that either there was no conflict of interest for the physician involved, the physician would receive a $2,000 finder's fee for each patient enrolled in the study, or the physician was a patent holder of the study drug. They also presented to patients one of three randomly assigned sponsors: a nonprofit research foundation, the U.S. government, or a pharmaceutical company.

Of the patients approached, 789 (70 percent) completed a questionnaire about clinical trial participation. About a third of all patients expressed interest in participation, whether or not there was a disclosed conflict of interest. More than half of the patients (55 percent) said they felt it was

Contact: Karen Blum
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Clinical judgement still counts strongly alongside genetic testing
3. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
4. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
5. DFG to establish seven new Clinical Research Units
6. NIH establishes Rare Diseases Clinical Research Network
7. Clinical study reports findings of combination therapy with DOXIL
8. Clinical study results published in NEJM show promising data on Antegren (natalizumab)
9. Clinical trial shows timing of chemotherapy improves survival in breast cancer
10. Clinical services must catch up
11. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase

Post Your Comments:

(Date:3/2/2020)... ... 2020 , ... Nominations are now being accepted for the 2020 Women ... (SIA) and SecureIDNews and co-presented with sponsors IDEMIA , ... of this year’s Women in Biometrics Awards will be honored at the 2020 SIA ...
(Date:2/28/2020)... ... 2020 , ... Meridian Clinical Research , a leading investigative research network, ... for Best Clinical Trial Site. Meridian is also the largest member of Platinum ... These nominations were the result of two voting rounds, and winners will be announced ...
(Date:2/28/2020)... ... February 27, 2020 , ... An ... innovative treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s ... segment will focus on a novel platform developed by Deka Biosciences, Inc. (Deka ...
Breaking Biology News(10 mins):
(Date:3/12/2020)... ... March 12, 2020 , ... ... microscopy (AFM) technology, increases the business investment in Europe by inaugurating a new ... Grand Opening Ceremony of the new Nanoscience Center Europe took place Tuesday, February ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... services, today announced the launch of its FleXpress™ high-throughput recombinant antibody production ... of antibodies at 80 ml scale. All production occurs in Absolute Antibody’s ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik ... list in the field of Biotechnology and Organics. , According to statistics compiled by ... of 259 patents issued in technology center 1600 during 2019. Technology center 1600 at ...
(Date:2/21/2020)... (PRWEB) , ... February 20, ... ... an exquisite capability to perform complex, efficient and elegant chemistry. Humans have ... algorithms to our own goals. , Through rapidly evolving technologies and strategies ...
Breaking Biology Technology:
Cached News: